TPC
DNLI icon

Takeda Pharmaceutical Company’s Denali Therapeutics DNLI Stock Holding History

Takeda Pharmaceutical Company’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,214,559
Closed -$97.9M – 11
2024
Q2 		$97.9M Hold
4,214,559
– – 42.13% 1
2024
Q1 		$86.5M Hold
4,214,559
– – 29.92% 2
2023
Q4 		$86.9M Buy
+4,214,559
New +$86.9M 26.55% 2